Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of BCG Revaccination Compared With Oral Chemoprophylaxis in Household Contacts Aged 6-18 Years for Prevention of Tuberculosis Disease - A Phase III Open Labelled Randomised Controlled Trial

NCT05330884 is registered in ClinicalTrials.gov with Tuberculosis Research Centre, India as lead sponsor.

NCT NCT05330884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05330884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of BCG Revaccination Compared With Oral Chemoprophylaxis in Household Contacts Aged 6-18 Years for Prevention of Tuberculosis Disease - A Phase III Open Labelled Randomised Controlled Trial
Lead sponsor
Tuberculosis Research Centre, India
Phase
Phase 3
Overall status
Suspended
Start date
July 15, 2024
Completion date
December 31, 2027
Enrollment
9,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, tuberculosis infection